COVID-19 will further exacerbate global antimicrobial resistance

J Travel Med. 2020 Sep 26;27(6):taaa098. doi: 10.1093/jtm/taaa098.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antimicrobial Stewardship
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Drug Resistance, Bacterial*
  • Global Health
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Anti-Bacterial Agents